01.01.2024 | Case report
Atezolizumab/bevacizumab
Isolated adrenocorticotropic hormone deficiency, inflammatory arthritis and lack of efficacy
Erschienen in: Reactions Weekly | Ausgabe 1/2024
Einloggen, um Zugang zu erhaltenExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event